Epidemiology and antimicrobial susceptibilities of wound isolates of obligate anaerobes from combat casualties

Diagn Microbiol Infect Dis. 2016 Feb;84(2):144-50. doi: 10.1016/j.diagmicrobio.2015.10.010. Epub 2015 Oct 23.

Abstract

Data from recent conflicts related to war wounds and obligate anaerobes are limited. We define the epidemiology and antimicrobial susceptibility of obligate anaerobes from Iraq and Afghanistan casualties (6/2009-12/2013), as well as their association with clinical outcomes. Susceptibility against eleven antibiotics (7 classes) was tested. Overall, 59 patients had 119 obligate anaerobes identified (83 were first isolates). Obligate anaerobes were isolated 7-13 days post-injury, primarily from lower extremity wounds (43%), and were largely Bacteroides spp. (42%) and Clostridium spp. (19%). Patients with pelvic wounds were more likely to have Bacteroides spp. and concomitant resistant gram-negative aerobes. Seventy-three percent of isolates were resistant to ≥1 antimicrobials. Bacteroides spp. demonstrated the most resistance (16% of first isolates). Patients with resistant isolates had similar outcomes to those with susceptible strains. Serial recovery of isolates occurred in 15% of patients and was significantly associated with isolation of Bacteroides spp., along with resistant gram-negative aerobes.

Keywords: Anaerobes; Antimicrobial susceptibility; Trauma-related infections; War wounds.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Adult
  • Afghanistan
  • Anti-Bacterial Agents / pharmacology*
  • Bacteria, Anaerobic / classification
  • Bacteria, Anaerobic / drug effects*
  • Bacteria, Anaerobic / isolation & purification
  • Bacterial Infections / epidemiology*
  • Bacterial Infections / microbiology*
  • Drug Resistance, Bacterial
  • Humans
  • Iraq
  • Male
  • Microbial Sensitivity Tests
  • Treatment Outcome
  • Warfare
  • Wound Infection / epidemiology*
  • Wound Infection / microbiology*
  • Wounds and Injuries / complications*
  • Young Adult

Substances

  • Anti-Bacterial Agents